top of page
MEDIMYNDS
MEDIMYNDS
Unlocking the Power of Medication-Adherence
Medimynds uniquely facilitates a patient-tailored dialogue for providers to use with each patient in medical encounters to improve medication-adherence
Home: Welcome
Home: About Us
WHO WE ARE
We are dedicated to improving patients' health through enhanced medication-adherence, creating profits for providers and health systems.
Our decade-long research shows that effective communication is not one-size-fits-all.
We tailor messages to each patient's unique socio-psychological profile.
Admynds, our innovative platform, enables providers to engage in personalized dialogues in real-time, significantly boosting medication-adherence.
With proven success in a hospital-based trial, our platform will transform patient-provider communication, benefiting patients, providers, and health systems.
WHY MEDIMYNDS?
Medimynds isn't just another platform; it's an innovative solution for value-based healthcare
where every improvement matters, enabling health systems to unlock their full potential.
Our platform facilitates profits, bonuses, and efficiency while reducing risk.
Our platform frees providers from the time-consuming process of psychological assessment.
Our messaging enhances MA across population groups in virtual encounters, reducing inequity for the disadvantaged.
Medimynds does the work for providers, allowing them to dedicate more time to what they do
best: patient care.
Medimynds is designed to enable a seamless integration across all medical encounters, physical
or digital, adapting to the workflow of providers, requiring no extra time or effort.
Home: Our Technology
"It is worthwhile to enhance medication-adherence rather than to develop new drugs."
Menashe Rothschild
Product Manager Officer
Professor
Gillie Gabay, Founder
Glenn Zemel, MD,
Chief Medical Officer
Pic_edited_edited_edited_edited_edited.jpg)
Shmulik Kaplan, Ph.D
Chief Technology Officer
MEET THE TEAM
Home: Quote
Home: Our Team
bottom of page